Iodixanol Nasal Solution Reduces Allergic Rhinoconjunctivitis Signs and Symptoms in Allergen BioCube®: Randomized Clinical Trial
<p>Importance: Allergic rhinitis affects about 20% of the population worldwide. Available pharmacological treatments are helpful but not ideal in providing relief; safer and more effective treatments are needed.</p><p>Objective: To evaluate the efficacy and safety of Nasapaque nasa...
Saved in:
Main Authors: | Gomes PJ (Author), Abelson MB (Author), Stein L (Author), Viirre E (Author), Villafranca JE (Author), Lasser EC (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Allergy - Peertechz Publications,
2018-10-05.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of modern allergens on allergic diseases: A prospective
by: YRKM Sai
Published: (2020) -
Allergen
Published: (2017) -
Animal allergens: Common protein characteristics featuring their allergenicity
by: Christiane Hilger
Published: (2015) -
Serum levels of Vitamin A and Atopic Rhinoconjunctivitis in Swedish adolescents
by: Malin Barman, et al.
Published: (2017) -
Sinus or nasal surgery alleviates headache symptoms: A prospective study
by: Vegard Bugten, et al.
Published: (2018)